Insulet Corp (PODD)
265.70
+2.47
(+0.94%)
USD |
NASDAQ |
Dec 26, 16:00
265.70
0.00 (0.00%)
After-Hours: 16:17
Insulet Research and Development Expense (Quarterly): 54.90M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Globus Medical Inc | 35.38M |
Boston Scientific Corp | 407.00M |
Haemonetics Corp | 16.53M |
LeMaitre Vascular Inc | 3.656M |
Tandem Diabetes Care Inc | 51.11M |